Drug Target Review2024-05-08T15:00:42
Researchers showed that ESI1, or similar compounds, may help to slow or even reverse cognitive losses that can occur during aging.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2023-09-06T16:55:04
Sponsored by NanoTemper Technologies
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2024-02-01T11:52:50
Sponsored by Leica Microsystems
2023-02-23T14:02:18
Sponsored by bit.bio
2026-06-09T08:20:00
Contributor Steve Smith, Drug Target Review
Site powered by Webvision Cloud